Clinical Trials · NCT07257484
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Weill Medical College of Cornell University
- Enrollment
- 30
- Start date
- Jun 2026
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of participants completing week 24 visit with all required assessments